ELTX – elicio therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ELTX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/12

07:13 am

eltx

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024 [Yahoo! Finance]

High Report

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024 [Yahoo! Finance]

Report

12/12

07:00 am

eltx

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

Medium Report

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

Report

12/3

07:18 am

eltx

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment [Yahoo! Finance]

Low Report

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment [Yahoo! Finance]

Report

12/3

07:00 am

eltx

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

Low Report

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

Report

11/13

04:05 pm

eltx

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Medium Report

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Report

11/7

04:05 pm

eltx

Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting

Medium Report

Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting

Report

10/31

08:30 am

eltx

Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit

Low Report

Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit

Report

10/16

08:30 am

eltx

Elicio Therapeutics Reports Inducement Grants

Medium Report

Elicio Therapeutics Reports Inducement Grants

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.